![]() |
[Home] [Databases] [World Law] [Multidatabase Search] [Help] [Feedback] | |
England and Wales Court of Appeal (Civil Division) Decisions |
||
You are here: BAILII >> Databases >> England and Wales Court of Appeal (Civil Division) Decisions >> Boehringer Ingelheim KG & Anor v Swingward Ltd [2008] EWCA Civ 881 (31 July 2008) URL: http://www.bailii.org/ew/cases/EWCA/Civ/2008/881.html Cite as: [2008] EWCA Civ 881 |
[New search] [Printable RTF version] [Help]
0682, 0689, 0690, 0691, 0692, 0693, 0694 |
COURT OF APPEAL (CIVIL DIVISION)
ON APPEAL FROM THE HIGH COURT OF JUSTICE
CHANCERY DIVISION (PATENTS COURT)
THE HON MR JUSTICE LADDIE
HC 1999 No 00017, HC 1999 Nos 01894, 02053
HC 1999 No 02051, HC 1999 No 02054,
HC 1999 No 02904, HC 1999 No 03040
Strand, London, WC2A 2LL |
||
B e f o r e :
LORD JUSTICE TUCKEY
and
LORD JUSTICE JACOB
____________________
Boehringer Ingelheim KG Boehringer Ingelheim Pharma KG |
Claimants/Respond-ents |
|
- and - |
||
Swingward Limited |
Defendant/Appellant |
|
Between: Boehringer Ingelheim KG Boehringer Ingelheim Pharma KG |
Claimants/ Respondents |
|
-and- |
||
Dowelhurst Limited |
Defendant/Appellant |
|
Between: Glaxo Group Limited |
Claimant/ Respondent |
|
-and- |
||
Swingward Limited |
Defendant/Appellant |
|
Between: Glaxo Group Limited The Wellcome Foundation Limited |
Claimants/ Respond-ents |
|
-and- |
||
Dowelhurst Limited |
Defendant/Appellant |
|
Between: Smithkline Beecham plc Beecham Group plc Smithkline and French Laboratories Limited |
Claimants/Respond-ents |
|
-and- |
||
Dowelhurst Limited |
Defendant/Appellant |
|
Between: Eli Lilly and Company |
Claimant/ Respondent |
|
-and- |
||
Dowelhurst Limited |
Defendant/Appellant |
____________________
Simon Thorley QC (instructed by CMS Cameron McKenna) appeared on behalf of Eli Lilly
Michael Silverleaf QC and Richard Hacon (instructed by REDD) appeared on behalf of Glaxo Group Limited, Boehringer Ingelheim and
Smithkline Beecham plc
Hearing Date: By Written Submissions
____________________
Crown Copyright ©
Lord Justice Jacob (giving the judgment of the court):
20% of £1.2m = £240,000
80% of that = £192,000
Half that by way of interim payment = £96,000
That is what we award by way of interim payment from Lilly.
15% of £1.2m = £180,000
80% of that = £144,000 (with liberty to apply following the Austrian judgment)
Half of that by way of interim payment = £72,000
That is what we award by way of interim payment from SKB.
(1) Applying Mr Arnold's %ages to the £1.2m one gets:
35% Boehringer = £420,000
30% Glaxo = £360,000
(2) The defendants get 95% of this:
Boehringer £399,000
Glaxo = £342,000
(3) But they only get 80% now with liberty to apply for the remainder after the Austrian judgment. So:
Boehringer £319,200
Glaxo £273,600
(4) 50% by way of interim payment gives half these numbers:
Boehringer £159,600
Glaxo £136,800